Omtryg
Product Images NDC 61112-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Omtryg (NDC 61112-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trygg Pharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epa Ethyl Ester Structural Formula (Image 01)

FDA Label Image

Dha Ethyl Ester Structural Formula (Image 02)

FDA Label Image

Principal Display Panel (Bottle Label)

Principal Display Panel (Bottle Label)
Each capsule of Omtryg contains 1.2 grams of omega-3-acid ethyl esters type A. The concentrate consists of at least 900 mg omega-3-acid ethyl esters, comprising 465 mg of ecosapentaenoic acid (EPA) ethyl ester and 375 mg of docosahexaenoic acid (DHA) ethyl ester. The usual dosage is mentioned in the prescribing information, and the capsules should be swallowed whole and not broken, chewed, or dissolved. The product should be stored within controlled room temperature. Omtryg is manufactured by Swiss Caps AG and is distributed by Tiygg Pharma Inc. It comes in a tightly sealed, light-resistant container that should be kept away from children and not frozen. The text also contains information on the expiration date, NDC number, and Rx only label.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.